Company research
Nautilus Biotechnology, Inc.
CIK 1808805Updated Sep 27, 2026
SecurityNAUT · NASDAQ · equity
Historical securities (1)
ARYA · NASDAQ · equity · closed Jun 9, 2021Name history
ARYA Sciences Acquisition Corp III · through Jun 8, 2021
NAUT price & chart
Loading TradingView…
NASDAQ:NAUT on TradingView ↗In the news
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 191,112,000Source | 242,743,000Source | 305,565,000Source | 350,052,000Source |
| Property, Plant and Equipment, NetUSD | 3,457,000Source | 4,076,000Source | 4,267,000Source | 3,700,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,388,000Source | 27,646,000Source | 19,397,000Source | 114,523,000Source |
| Assets, CurrentUSD | 105,963,000Source | 132,826,000Source | 176,837,000Source | 187,209,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,557,000Source | 2,933,000Source | 3,419,000Source | 2,738,000Source |
| Operating Lease, Right-of-Use AssetUSD | 27,773,000Source | 28,256,000Source | 32,634,000Source | 28,866,000Source |
| Other Assets, NoncurrentUSD | 1,180,000Source | 1,180,000Source | 1,180,000Source | 1,108,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 34,139,000Source | 34,013,000Source | 40,212,000Source | 35,128,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 13,000Source | 13,000Source | 13,000Source | 12,000Source |
| Additional Paid in CapitalUSD | 488,737,000Source | 481,679,000Source | 467,834,000Source | 455,330,000Source |
| Retained Earnings (Accumulated Deficit)USD | -332,020,000Source | -273,019,000Source | -202,239,000Source | -138,564,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 243,000Source | 57,000Source | -255,000Source | -1,854,000Source |
| Stockholders' Equity Attributable to ParentUSD | 156,973,000Source | 208,730,000Source | 265,353,000Source | 314,924,000Source |
| Liabilities and EquityUSD | 191,112,000Source | 242,743,000Source | 305,565,000Source | 350,052,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,952,000Source | 7,632,000Source | 9,122,000Source | 6,791,000Source |
| Operating Lease, Liability, CurrentUSD | 3,832,000Source | 4,097,000Source | 3,538,000Source | 1,991,000Source |
| Accounts Payable, CurrentUSD | 943,000Source | 987,000Source | 1,639,000Source | 1,272,000Source |
| Operating Lease, Liability, NoncurrentUSD | 26,187,000Source | 26,381,000Source | 31,090,000Source | 28,337,000Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 103,400,000Source | 129,900,000Source | 173,400,000Source | 184,500,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 6,844,000Source | 12,701,000Source | 12,137,000Source | 10,380,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -69,000Source | -578,000Source | 393,000Source | -561,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -50,696,000Source | -59,145,000Source | -51,711,000Source | -45,806,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 35,224,000Source | 66,250,000Source | -43,735,000Source | -25,740,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 1,277,000Source | 2,122,000Source | 2,442,000Source | 2,324,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 214,000Source | 1,144,000Source | 368,000Source | 562,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -15,258,000Source | 8,249,000Source | -95,078,000Source | -70,984,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 13,390,000Source | 28,648,000Source | 20,399,000Source | 115,477,000Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 103,400,000Source | 129,900,000Source | 173,400,000Source | 184,500,000Source |
| DepreciationUSD | 1,700,000Source | 1,975,000Source | 1,849,000Source | 1,217,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | -84,000Source | — | 0Source |
| General and Administrative ExpenseUSD | 25,727,000Source | 30,999,000Source | 28,901,000Source | 25,946,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Nonoperating Income (Expense)USD | 7,836,000Source | 10,696,000Source | 12,477,000Source | 5,694,000Source |
| Operating ExpensesUSD | 66,837,000Source | 81,476,000Source | 76,152,000Source | 63,618,000Source |
| Proceeds from Stock Options ExercisedUSD | 58,000Source | 620,000Source | 104,000Source | 330,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Earnings Per Share, BasicUSD per share | -0.47Source | -0.56Source | -0.51Source | -0.46Source |
| Earnings Per Share, DilutedUSD per share | -0.47Source | -0.56Source | -0.51Source | -0.46Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 126,256,583Source | 125,426,509Source | 124,919,144Source | 124,589,555Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 126,256,583Source | 125,426,509Source | 124,919,144Source | 124,589,555Source |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 25,727,000Source | 30,999,000Source | 28,901,000Source | 25,946,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 7,868,000Source | 10,780,000Source | 12,550,000Source | 5,816,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Nonoperating Income (Expense)USD | 7,836,000Source | 10,696,000Source | 12,477,000Source | 5,694,000Source |
| Operating ExpensesUSD | 66,837,000Source | 81,476,000Source | 76,152,000Source | 63,618,000Source |
| Research and Development ExpenseUSD | 41,110,000Source | 50,477,000Source | 47,251,000Source | 37,672,000Source |